Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Preliminary results
Quarterly results
|
|
MARAVAI LIFESCIENCES HOLDINGS, INC.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/22/2023 |
4
| MARTIN WILLIAM E. III (CEO) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 300,000 rights
@ $0 |
|
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/07/2023 |
8-K
| Quarterly results |
| 07/27/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/20/2023 |
8-K
| Quarterly results |
| 07/19/2023 |
4
| Herde Kevin (CFO) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 874 shares
@ $11.72, valued at
$10.2k
|
|
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Dolan Christine (See Remarks) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 1,394 shares
@ $11.72, valued at
$16.3k
|
|
| 07/19/2023 |
4
| Hopfield Jessica (Director) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 24,000 shares
@ $0 |
|
| 07/19/2023 |
4
| Leddy Peter Michael (See Remarks) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 1,920 shares
@ $11.72, valued at
$22.5k
Paid exercise price by delivering 5,578 shares
@ $12.52, valued at
$69.8k
|
|
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Ashkenazi Anat (Director) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 24,000 shares
@ $0 |
|
| 07/19/2023 |
4
| LUCIER GREGORY T (Director) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 24,000 shares
@ $0 |
|
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| MIHAS CONSTANTINE S (Director) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 24,000 shares
@ $0 |
|
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/08/2023 |
8-K
| Quarterly results |
| 04/20/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/20/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/17/2023 |
4
| ORESHACK KURT (General Counsel) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 38,386 shares
@ $0
Granted 76,500 options to buy
@ $15.52, valued at
$1.2M
|
|
| 03/17/2023 |
4
| Leddy Peter Michael (See Remarks) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 72,507 shares
@ $0
Granted 143,000 options to buy
@ $15.52, valued at
$2.2M
|
|
| 03/17/2023 |
4
| Herde Kevin (CFO) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 72,507 shares
@ $0
Granted 143,000 options to buy
@ $15.52, valued at
$2.2M
|
|
| 03/17/2023 |
4
| Dolan Christine (See Remarks) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 55,775 shares
@ $0
Granted 110,000 options to buy
@ $15.52, valued at
$1.7M
|
|
| 03/17/2023 |
4
| HULL CARL (CEO) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 147,638 shares
@ $0
Granted 270,109 options to buy
@ $15.52, valued at
$4.2M
|
|
| 03/13/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/10/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 02/28/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/22/2023 |
8-K
| Quarterly results |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 7.9% stake in Maravai LifeSciences Holdings Inc. Class A |
|
|
|